Cover Image

The Potential Therapeutic Prospect of PANoptosis in Heart Failure

Yunfeng Jia,1 Yayi Liu,1 Yiming Zuo,1 Junping Zhang,1 Yanyang Li,2,3 Xuezheng Liu,1 Shichao Lv1 1Department of Geriatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion), Tianjin, 3003...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia Y (Author), Liu Y (Author), Zuo Y (Author), Zhang J (Author), Li Y (Author), Liu X (Author), Lv S (Author)
Format:	Book
Published:	Dove Medical Press, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis
by: Shi C, et al.
Published: (2023)

PANoptosis-Relevant Subgroups Predicts Prognosis and Characterizes the Tumour Microenvironment in Ovarian Cancer
by: Chen Y, et al.
Published: (2024)

Identification of Independent and Communal Differentially Expressed Genes as Well as Potential Therapeutic Targets in Ischemic Heart Failure and Non-Ischemic Heart Failure
by: Wang Z, et al.
Published: (2021)

Targeting the PANoptosis signaling pathway for myocardial protection: therapeutic potential of Xian Ling Gu Bao capsule
by: Xiaoyu Wu, et al.
Published: (2024)

Machine Learning Screening and Validation of PANoptosis-Related Gene Signatures in Sepsis
by: Xu J, et al.
Published: (2024)

A Pilot Study About the Role of PANoptosis-Based Genes in Atherosclerosis Development
by: Chen H, et al.
Published: (2023)

AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine
by: Liu C, et al.
Published: (2023)

Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study
by: Cheng X, et al.
Published: (2020)

Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders
by: Liu X, et al.
Published: (2017)

Energy metabolism disorders and potential therapeutic drugs in heart failure
by: Yanan He, et al.
Published: (2021)

Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
by: Qiujin Jia, et al.
Published: (2019)

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
by: Xianyanling Yi, et al.
Published: (2023)

Review of Microneedle Technology for Targeted Therapeutics in Vitiligo: Design Principles, Application Prospects
by: Yu Y, et al.
Published: (2024)

Investigating the Mechanism of Action of Schisandra chinensis Combined with Coenzyme Q10 in the Treatment of Heart Failure Based on PI3K-AKT Pathway
by: Wen S, et al.
Published: (2023)

Therapeutic Potential of Vasopressin-Receptor Antagonists in Heart Failure
by: Yasukatsu Izumi, et al.
Published: (2014)

Ryanodine receptor in heart failure: potential therapeutic sites.
by: Guy Vasort
Published: (2010)

Ryanodine receptor in heart failure: potential therapeutic sites.
by: Guy Vassort
Published: (2011)

Prognostic Value of Inflammatory Cytokines in Predicting Hospital Readmissions in Heart Failure with Preserved Ejection Fraction
by: Zhao Z, et al.
Published: (2024)

Identification and Analysis of PANoptosis-Related Genes in Sepsis-Induced Lung Injury by Bioinformatics and Experimental Verification
by: Yang Z, et al.
Published: (2024)

Qifu Yixin Formula Improves Heart Failure by Enhancing β-Arrestin2 Mediated the SUMOylation of SERCA2a
by: Wang X, et al.
Published: (2024)

Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy
by: Lin J, et al.
Published: (2023)

Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up
by: Xu X, et al.
Published: (2023)

A Survival Prediction for Acute Heart Failure Patients via Web-Based Dynamic Nomogram with Internal Validation: A Prospective Cohort Study
by: Yin T, et al.
Published: (2022)

Web-Based Dynamic Nomogram for Predicting Risk of Mortality in Heart Failure with Mildly Reduced Ejection Fraction
by: Guo W, et al.
Published: (2024)

Transitional Care in Patients with Heart Failure: A Concept Analysis Using Rogers’ Evolutionary Approach
by: Liu S, et al.
Published: (2023)

Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects
by: Qi Y, et al.
Published: (2024)

Identification of Ferroptosis-Related Genes in Heart Failure Induced by Transverse Aortic Constriction
by: Gu JJ, et al.
Published: (2023)

PANoptosis and Autophagy-Related Molecular Signature and Immune Landscape in Ulcerative Colitis: Integrated Analysis and Experimental Validation
by: Lu J, et al.
Published: (2024)

Identification of Shared Signature Genes and Immune Microenvironment Subtypes for Heart Failure and Chronic Kidney Disease Based on Machine Learning
by: Wang X, et al.
Published: (2024)

HEART RATE VARIABILITY IN ASSESSMENT OF CLINICAL STATUS, FUNCTIONAL CONDITIONS AND PROGNOSIS IN HEART FAILURE
by: Y. A. Vasyuk, et al.
Published: (2016)

Assessing the Prediction Effect of Various Prognosis Model for 28-Day Mortality in Acute-on-Chronic Liver Failure Patients
by: Liu LX, et al.
Published: (2020)

A Novel Nomogram Integrated with Systemic Inflammation Markers and Traditional Prognostic Factors for Adverse Events’ Prediction in Patients with Chronic Heart Failure in the Southwest of China
by: Liu Z, et al.
Published: (2022)

Potential therapeutic effects of Cordyceps cicadae and Paecilomyces cicadae on adenine-induced chronic renal failure in rats and their phytochemical analysis
by: Li L, et al.
Published: (2018)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015)

Intestinal dysbiosis in heart failure - modulation of dysbiosis as a potential therapeutic target
by: Joanna Osiak, et al.
Published: (2023)

β-Hydroxybutyrate Mitigated Heart Failure with Preserved Ejection Fraction by Increasing Treg Cells via Nox2/GSK-3β
by: Liao S, et al.
Published: (2021)

Discovery and Validation of Potential Serum Biomarkers for Heart Failure by Untargeted Metabolomics
by: Guisheng Zhou, et al.
Published: (2024)

A Chronic Multiple Site of Scrofuloderma: Is It Reactivation or Treatment Failure of Tuberculosis?
by: Yang X, et al.
Published: (2023)

Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study
by: Dr Hisham Dokainish, MD, et al.
Published: (2017)